Orthopediatrics

Orthopediatrics Corp (NASDAQ: KIDS) is poised to achieve strong top-line growth due to its exclusive focus on the sizeable and largely underserved $2.5 billion pediatric orthopedic market, according to Stifel.  Stifel initiated coverage of Orthopediatrics with a Buy rating and a $23 price...